康缘药业: 江苏康缘药业股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告

Core Viewpoint - Jiangsu Kangyuan Pharmaceutical Co., Ltd. has undergone a special audit regarding non-operating fund occupation and other related fund transactions for the year 2024, with the audit conducted by Lixin Accounting Firm [1] Group 1: Audit Overview - The audit covered the financial statements of Jiangsu Kangyuan Pharmaceutical Co., Ltd. for the year ending December 31, 2024, including consolidated and parent company balance sheets, income statements, cash flow statements, and changes in equity [1] - The audit report issued on April 2, 2025, was a clean opinion report, indicating no significant discrepancies found [1] Group 2: Non-operating Fund Occupation - The management of Jiangsu Kangyuan Pharmaceutical prepared a summary table of non-operating fund occupation and other related fund transactions for 2024, in compliance with regulatory requirements [1] - The summary table is intended to be read in conjunction with the audited financial statements to provide a clearer understanding of the company's financial dealings [1] Group 3: Financial Data - The summary table includes detailed information on non-operating fund occupation, with specific amounts and nature of transactions listed [2] - Total non-operating fund occupation for the year 2024 amounted to 30,216.63 million, with cumulative amounts and repayment details provided [2]